US Map / Wisconsin
State WI

Clinical Trials in Wisconsin

Wisconsin is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Wisconsin and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 190 actively recruiting studies with Wisconsin sites out of 190 registered in total. The busiest research areas in Wisconsin are Breast Cancer, Asthma, Burkitt Lymphoma. Leading sponsors running trials in the state include University of Wisconsin, Madison, National Cancer Institute (NCI), Medical College of Wisconsin. By stage, Wisconsin trials break down as Phase 1 (23), Phase 2 (49), Phase 3 (59), Phase 4 (6).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
190
Recruiting Now
190
← Back to US Map
Top Conditions in Wisconsin
Breast Cancer (6)Asthma (4)Burkitt Lymphoma (3)Metastatic Cancer (3)Acute Myeloid Leukemia (3)Ovarian Cancer (3)Stroke (3)Melanoma (3)Non-Small Cell Lung Cancer (3)Prostate Cancer (3)Multiple Myeloma (3)Metastatic Breast Cancer (2)

Frequently Asked Questions — Clinical Trials in Wisconsin

How many clinical trials are currently recruiting in Wisconsin?
ClinicalMetric currently tracks 190 actively recruiting clinical trials with at least one location in Wisconsin. The total number of registered studies—including active but not currently enrolling trials—is 190. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Wisconsin?
Wisconsin hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Asthma, Burkitt Lymphoma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Wisconsin serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Wisconsin?
To join a clinical trial in Wisconsin, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Wisconsin maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Wisconsin

NCT05136196 Phase 2
Recruiting
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Tr...
Condition
Clinical Stage III Cutaneous Melanoma AJCC v8
Enrollment
150 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05794880 N/A
Recruiting
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Condition
Leukemia
Enrollment
40 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT05317403 Phase 1
Recruiting
Venetoclax to Augment Epigenetic Modification and Chemotherapy
Condition
Acute Myeloid Leukemia, in Relapse
Enrollment
40 pts
Location
United States
Sponsor
Medical College of Wisconsin
View Trial →
NCT07259746 N/A
Recruiting
Study of Student Flourishing
Condition
Healthy
Enrollment
2,500 pts
Location
United States, Canada, New Zealand
Sponsor
Flourish Science, Inc.
View Trial →
NCT06279013 N/A
Recruiting
Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and P...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
600 pts
Location
United States, Puerto Rico
Sponsor
NRG Oncology
View Trial →
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06350097 Phase 3
Recruiting
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotama...
Condition
Non-small Cell Lung Cancer
Enrollment
582 pts
Location
United States, Australia, Brazil
Sponsor
AstraZeneca
View Trial →
NCT06548360 Phase 3
Recruiting
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Pa...
Condition
NonSegmental Vitiligo
Enrollment
180 pts
Location
United States, Canada
Sponsor
Incyte Corporation
View Trial →
NCT06672146 Phase 2
Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia ...
Condition
Acute Myeloid Leukemia
Enrollment
93 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT05489588 N/A
Recruiting
The GORE® VIABAHN® FORTEGRA Venous Stent Iliofemoral Study
Condition
Venous Thromboses
Enrollment
165 pts
Location
United States
Sponsor
W.L.Gore & Associates
View Trial →
NCT06787612 Phase 2
Recruiting
Investigation of Ubamatamab Combination Therapy in Adult Participants With Plati...
Condition
Ovarian Cancer
Enrollment
220 pts
Location
United States, Canada, South Korea
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
View Trial →
NCT05147792 N/A
Recruiting
The CONFORM Pivotal Trial
Condition
Atrial Fibrillation
Enrollment
1,600 pts
Location
United States, Czechia, France
Sponsor
Conformal Medical, Inc
View Trial →
NCT06844383 Phase 2
Recruiting
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Canc...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
126 pts
Location
United States
Sponsor
Prostate Cancer Clinical Trial
View Trial →
NCT07173751 Phase 3
Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-N...
Condition
Breast Neoplasms
Enrollment
558 pts
Location
United States, Australia, Belgium
Sponsor
BioNTech SE
View Trial →
NCT06655246 Phase 1
Recruiting
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gas...
Condition
Gastrointestinal Stromal Tumor (GIST)
Enrollment
157 pts
Location
United States
Sponsor
Kura Oncology, Inc.
View Trial →
NCT05638581 Phase 3
Recruiting
Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Condition
Wounds and Injuries
Enrollment
1,100 pts
Location
United States
Sponsor
University of Alabama at Birmi
View Trial →
NCT06780137 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatama...
Condition
Small Cell Lung Cancer
Enrollment
327 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
View Trial →
NCT05580419 N/A
Recruiting
Impact of 4PCP on Practitioner and Patient Outcomes
Condition
Chronic Pain
Enrollment
1,188 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
View Trial →
NCT06855433 Phase 2
Recruiting
Colchicine to Reduce Your SympToms And Lower Levels of Inflammation, Zeroing in ...
Condition
CPPD - Calcium Pyrophosphate Deposition Disease
Enrollment
150 pts
Location
United States
Sponsor
Brigham and Women's Hospital
View Trial →
NCT06938347 Phase 3
Recruiting
Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Rig...
Condition
Right-To-Left Shunt
Enrollment
300 pts
Location
United States, Canada
Sponsor
Agitated Solutions, Inc.
View Trial →
NCT04718168 N/A
Recruiting
GORE® ENFORM Biomaterial Product Study
Condition
Hernia, Ventral
Enrollment
245 pts
Location
United States
Sponsor
W.L.Gore & Associates
View Trial →
NCT06337318 Phase 3
Recruiting
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor ...
Condition
Classic Follicular Lymphoma
Enrollment
600 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT04786262 Phase 3
Recruiting
A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1...
Condition
Diabetes Mellitus, Type 1
Enrollment
52 pts
Location
United States, Canada, France
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC
View Trial →
Page 2 of 8 — 190 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology